Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
1000000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
20th Series of Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
発行・処分する株式数
1,000,000 new shares (number of shares delivered in August 2026)
Existing Shares and Increase
+0.38%Rate of increase
282,667,319 shares283,667,319Shares
0.38% (1,000,000 shares delivered during the period covered, including all series / 264,729,198 listed shares outstanding as of the payment date for the issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥24.00 or ¥24.70 (exercise status during the month covered). Details of the adjustment clause and the adjustment floor: not disclosed
Number of Stock Acquisition Rights
Total number issued: 591,499 units (calculated from the statement that 10,000 units represented 1.69% of the total number issued). Unexercised at the end of the preceding month: 419,499 units; unexercised as of the current date: 409,499 units
Procedures under the Corporate Code of Conduct
The exercise ratio subject to the exercise restrictions is disclosed as the status of compliance with the exercise deadline under Article 434 of the Listing Regulations
Most recent equity financing
Timing 23 December 2025 / Type 20th Series of Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | 20th Series of Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 1,000,000 new shares (number of shares delivered in August 2026) |
| Dilution Rate | 0.38% (1,000,000 shares delivered during the period covered, including all series / 264,729,198 listed shares outstanding as of the payment date for the issuance) |
| Total number of issued shares | 282,667,319 shares (as of the end of the month preceding the period covered) → 283,667,319 shares (the number of shares outstanding as of the end of the preceding month plus 1,000,000 new shares delivered during the month covered) |
| Exercise price | ¥24.00 or ¥24.70 (exercise status during the month covered). Details of the adjustment clause and the adjustment floor: not disclosed |
| Number of Stock Acquisition Rights | Total number issued: 591,499 units (calculated from the statement that 10,000 units represented 1.69% of the total number issued). Unexercised at the end of the preceding month: 419,499 units; unexercised as of the current date: 409,499 units |
| Procedures under the Corporate Code of Conduct | The exercise ratio subject to the exercise restrictions is disclosed as the status of compliance with the exercise deadline under Article 434 of the Listing Regulations |
| Most recent equity financing | Timing 23 December 2025 / Type 20th Series of Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status in August 2026 of the 20th Series of Stock Acquisition Rights issued on 23 December 2025.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.